» Articles » PMID: 20472347

Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer

Abstract

Purpose: Accurate target definition is vitally important for definitive treatment of cervix cancer with intensity-modulated radiotherapy (IMRT), yet a definition of clinical target volume (CTV) remains variable within the literature. The aim of this study was to develop a consensus CTV definition in preparation for a Phase 2 clinical trial being planned by the Radiation Therapy Oncology Group.

Methods And Materials: A guidelines consensus working group meeting was convened in June 2008 for the purposes of developing target definition guidelines for IMRT for the intact cervix. A draft document of recommendations for CTV definition was created and used to aid in contouring a clinical case. The clinical case was then analyzed for consistency and clarity of target delineation using an expectation maximization algorithm for simultaneous truth and performance level estimation (STAPLE), with kappa statistics as a measure of agreement between participants.

Results: Nineteen experts in gynecological radiation oncology generated contours on axial magnetic resonance images of the pelvis. Substantial STAPLE agreement sensitivity and specificity values were seen for gross tumor volume (GTV) delineation (0.84 and 0.96, respectively) with a kappa statistic of 0.68 (p < 0.0001). Agreement for delineation of cervix, uterus, vagina, and parametria was moderate.

Conclusions: This report provides guidelines for CTV definition in the definitive cervix cancer setting for the purposes of IMRT, building on previously published guidelines for IMRT in the postoperative setting.

Citing Articles

Development and validation of a deep reinforcement learning algorithm for auto-delineation of organs at risk in cervical cancer radiotherapy.

Yucheng L, Lingyun Q, Kainan S, Yongshi J, Wenming Z, Jieni D Sci Rep. 2025; 15(1):6800.

PMID: 40000766 PMC: 11861648. DOI: 10.1038/s41598-025-91362-9.


Modeling dosimetric benefits from daily adaptive RT for gynecological cancer patients with and without knowledge-based dose prediction.

Ghimire R, Moore L, Branco D, Rash D, Mayadev J, Ray X J Appl Clin Med Phys. 2025; 26(3):e14596.

PMID: 39868634 PMC: 11905257. DOI: 10.1002/acm2.14596.


Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.

Ou D, Cai R, Qi W, Cui C, Cao L, Wang S Cancer Immunol Immunother. 2024; 73(12):244.

PMID: 39358560 PMC: 11447187. DOI: 10.1007/s00262-024-03823-1.


Weekly Image Guidance in Patients With Cervical Cancer Treated With Intensity-Modulated Radiation Therapy: Results of a Large Cohort Study.

Zeng Z, Wang W, Yan J, Liu D, Zhang F, Hu K Cancer Med. 2024; 13(18):e70269.

PMID: 39351618 PMC: 11443159. DOI: 10.1002/cam4.70269.


Moderated Hypofractionated Online Adaptive Radiotherapy in Locally Advanced Cervical Cancer: A Case Report.

Zeng Z, Zhang F, Yan J Cureus. 2024; 16(8):e66552.

PMID: 39252725 PMC: 11381937. DOI: 10.7759/cureus.66552.